Trial Details
COMPLETEDBasic Information
| Clinical ID | c2934 |
|---|---|
| Identifier | NCT02764762 |
| Trial Title | Triple Combination Therapy in High Risk Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Vedolizumab|DRUG: Adalimumab|DRUG: Methotrexate |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2017-04-18 |
|---|---|
| Primary Completion Date | 2020-09-22 |
| Completion Date | 2022-07-05 |